mTOR Signaling Pathway Is a Target for the Treatment of Colorectal Cancer

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Annals of Surgical Oncology

• Publication date

  2009-06-11

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1245/s10434-009-0555-9PMID 19517193
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Combined Inhibition of MEK and mTOR Signaling Inhibits Initiation and Progression of Colorectal Cancer

  2009influential reference
• Targeting mTOR with rapamycin: One dose does not fit all

  2009cited by this paper
• Phospho-mTOR and phospho-4EBP1 in endometrial adenocarcinoma: association with stage and grade in vivo and link with response to rapamycin treatment in vitro

  2009cited by this paper
• Targeting the eukaryotic translation initiation factor 4E for cancer therapy.

  2008cited by this paper
• Expression of an activated mammalian target of rapamycin in adenocarcinoma of the cervix: A potential biomarker and molecular target therapy

  2008cited by this paper
• Susceptibility for NSAIDs-Induced Apoptosis Correlates to p53 Gene Status in Gastric Cancer Cells

  2008cited by this paper
• Role of mTOR in solid tumor systems: a therapeutical target against primary tumor growth, metastases, and angiogenesis

  2007cited by this paper
• TOR-in(g) the Nucleus

  2007cited by this paper
• RNAi screening for therapeutic targets in human malignancies.

  2007cited by this paper
• Phosphorylation of ribosomal p70 S6 kinase and rapamycin sensitivity in human colorectal cancer.

  2007cited by this paper
• 4E-Binding Protein 1, A Cell Signaling Hallmark in Breast Cancer that Correlates with Pathologic Grade and Prognosis

  2007cited by this paper
• 4E-binding protein 1: a key molecular "funnel factor" in human cancer with clinical implications.

  2007cited by this paper
• siRNA-mediated knockdown of connective tissue growth factor prevents N-nitrosodimethylamine-induced hepatic fibrosis in rats

  2007cited by this paper
• Defining the role of mTOR in cancer.

  2007cited by this paper
• Targeting mammalian target of rapamycin (mTOR) for health and diseases.

  2007cited by this paper
• Targeting the mTOR signaling network in cancer.

  2007cited by this paper
• Cell cycle effects resulting from inhibition of hepatocyte growth factor and its receptor c‐Met in regenerating rat livers by RNA interference

  2007cited by this paper
• 2'-Modified oligonucleotides for antisense therapeutics.

  2007cited by this paper
• mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer.

  2007cited by this paper
• An activated mTOR/p70S6K signaling pathway in esophageal squamous cell carcinoma cell lines and inhibition of the pathway by rapamycin and siRNA against mTOR.

  2007cited by this paper
• Expanding the repertoire of RNA interference screens for developing new anticancer drug targets

  2007cited by this paper
• Chemical modification: the key to clinical application of RNA interference?

  2007cited by this paper
• A new inducible RNAi xenograft model for assessing the staged tumor response to mTOR silencing.

  2006cited by this paper
• TOR signaling in growth and metabolism.

  2006cited by this paper
• RNA Interference-Mediated Gene Silencing of Pleiotrophin Through Polyethylenimine-Complexed Small Interfering RNAs In Vivo Exerts Antitumoral Effects in Glioblastoma Xenografts

  2006cited by this paper
• mTOR and cancer therapy

  2006cited by this paper
• mTOR, translation initiation and cancer

  2006cited by this paper
• Phosphorylated 4E binding protein 1: A hallmark of cell signaling that correlates with survival in ovarian cancer

  2006cited by this paper
• Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma.

  2006cited by this paper
• Therapeutic targets: MTOR and related pathways

  2006cited by this paper
• A plasmid-encoded VEGF siRNA reduces glioblastoma angiogenesis and its combination with interleukin-4 blocks tumor growth in a xenograft mouse model

  2006cited by this paper
• From Rapa Nui to rapamycin: targeting PI3K/Akt/mTOR for cancer therapy

  2006cited by this paper
• Lost in translation: dysregulation of cap-dependent translation and cancer.

  2004cited by this paper
• Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive

  2004cited by this paper
• Involvement of the PI 3-kinase signaling pathway in progression of colon adenocarcinoma.

  2003cited by this paper
• mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery.

  2002cited by this paper
• World Health Organization Classification of Tumours

  2002cited by this paper
• Pathology and genetics of tumours of the digestive system

  2000cited by this paper

• From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies

  2024cites this paper
• CASTOR1 phosphorylation predicts poor survival in male patients with KRAS-mutated lung adenocarcinoma

  2024cites this paper
• The pathological role of C-X-C chemokine receptor type 4 (CXCR4) in colorectal cancer (CRC) progression; special focus on molecular mechanisms and possible therapeutics.

  2023cites this paper
• Serum levels of n-3 PUFA and colorectal cancer risk in Chinese population

  2023cites this paper
• Suppression of mTOR expression by siRNA leads to cell cycle arrest and apoptosis induction in MDA-MB-231 breast cancer cells.

  2023cites this paper
• iCircDA-NEAE: Accelerated attribute network embedding and dynamic convolutional autoencoder for circRNA-disease associations prediction

  2023cites this paper
• When You Come to a Fork in the Road, Take It: Wnt Signaling Activates Multiple Pathways through the APC/Axin/GSK-3 Complex

  2023cites this paper
• Magnetic gelatin nanoparticles as a biocompatible carrier system for small interfering RNA in human colorectal cancer: synthesis, optimization, characterization, and cell viability studies

  2022cites this paper
• Molecular recognition of some novel mTOR kinase inhibitors to develop anticancer leads by drug-likeness, molecular docking and molecular dynamics based virtual screening strategy

  2022cites this paper
• The importance of habitat in the tumor-associated Pten, Mtor, and Akt gene expressions and chromosomal aberrations for wild rats

  2022cites this paper
• Cytokine-induced killer cells mediated pathways in the treatment of colorectal cancer

  2022cites this paper
• Effect of MiR-10b on Cervical Cancer Rats Through mTOR/P70S6K Signaling Pathway.

  2022cites this paper
• Targeting mTOR as a Cancer Therapy: Recent Advances in Natural Bioactive Compounds and Immunotherapy

  2022cites this paper
• Exploration of the Key Proteins of High-Grade Intraepithelial Neoplasia to Adenocarcinoma Sequence Using In-Depth Quantitative Proteomics Analysis

  2021cites this paper
• Does Oral Apigenin Have Real Potential for a Therapeutic Effect in the Context of Human Gastrointestinal and Other Cancers?

  2021influential citation
• Investigating Differential Expression of mTOR1/UCA1 in Tumor Samples of Colorectal Cancer Compared with Tumor Marginal Samples

  2021cites this paper
• Phosphorylated mTOR expression as a predictor of survival after liver resection for colorectal liver metastases

  2021cites this paper
• Obesity and inflammation: colorectal cancer engines.

  2021cites this paper
• Portrait of Cancer Stem Cells on Colorectal Cancer: Molecular Biomarkers, Signaling Pathways and miRNAome

  2021cites this paper
• Human Positive Coactivator 4 Affects the Progression and Prognosis of Pancreatic Ductal Adenocarcinoma via the mTOR/P70s6k Signaling Pathway

  2020cites this paper
• Evaluation of the antitumor effects of PP242 in a colon cancer xenograft mouse model using comprehensive metabolomics and lipidomics

  2020cites this paper
• Prognostic role of aberrant mTOR activation in patients with stage II and III colorectal cancer.

  2020cites this paper
• p18/Lamtor1-mTORC1 Signaling Controls Development of Mucin-producing Goblet Cells in the Intestine

  2020influential citation
• Common Targets for a deadly duo of diabetes mellitus and colon cancer: Catching two fish with one worm.

  2020cites this paper
• mTOR Signaling Combined with Cancer Stem Cell Markers as a Survival Predictor in Stage II Colorectal Cancer

  2020cites this paper
• STAT3‐mediated MLST8 gene expression regulates cap‐dependent translation in cancer cells

  2020cites this paper
• Targeting Protein Synthesis in Colorectal Cancer

  2020cites this paper
• OTT_A_279024 11505..11516

  2020cites this paper
• Identification of Two Kinase Inhibitors with Synergistic Toxicity with Low-Dose Hydrogen Peroxide in Colorectal Cancer Cells In vitro

  2020cites this paper
• Cytochrome C Oxidase Assembly Factor 1 Homolog Predicts Poor Prognosis and Promotes Cell Proliferation in Colorectal Cancer by Regulating PI3K/AKT Signaling

  2020cites this paper
• Whole-Exome Sequencing Characterized the Landscape of Somatic Mutations and Pathways in Colorectal Cancer Liver Metastasis

  2019cites this paper
• miRDRN—miRNA disease regulatory network: a tool for exploring disease and tissue-specific microRNA regulatory networks

  2019cites this paper
• Fisetin and 5‐fluorouracil: Effective combination for PIK3CA‐mutant colorectal cancer

  2019cites this paper
• mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy

  2019cites this paper
• OTT_A_190998 10311..10321

  2019cites this paper
• Influence and mechanism of miR-99a suppressing development of colorectal cancer (CRC) with diabetes mellitus (DM)

  2019cites this paper
• Diet, Microbiota, and Colorectal Cancer

  2019cites this paper
• A system level approach to identify novel cell size regulators

  2019cites this paper
• Maintenance BEZ235 Treatment Prolongs the Therapeutic Effect of the Combination of BEZ235 and Radiotherapy for Colorectal Cancer

  2019cites this paper
• Plk2 Loss Commonly Occurs in Colorectal Carcinomas but not Adenomas: Relationship to mTOR Signaling

  2018influential citation
• Sorting nexin 10 controls mTOR activation through regulating amino-acid metabolism in colorectal cancer

  2018cites this paper
• Dose-response effects of exercise on insulin among colon cancer survivors.

  2018cites this paper
• Dual mTOR / PI 3 K inhibitor NVP ‐ BEZ 235 arrests colorectal cancer cell growth and displays differential inhibition of 4 E ‐ BP 1

  2018cites this paper
• mTORC1 Inactivation Promotes Colitis-Induced Colorectal Cancer but Protects from APC Loss-Dependent Tumorigenesis.

  2018cites this paper
• The Biological Activities of Oleocanthal from a Molecular Perspective

  2018cites this paper
• NF-κB-induced WIP1 expression promotes colorectal cancer cell proliferation through mTOR signaling.

  2018cites this paper
• The anti-osteosarcoma cell activity by a mTORC1/2 dual inhibitor RES-529.

  2018cites this paper
• Metabolic reprogramming and AMPKα1 pathway activation by caulerpin in colorectal cancer cells.

  2017cites this paper
• The role of DOK7 and its variants in colorectal cancer

  2017cites this paper
• Effects of bufalin on the mTOR/p70S6K pathway and apoptosis in esophageal squamous cell carcinoma in nude mice

  2017cites this paper
• The Translational Controlled Tumour Protein TCTP: Biological Functions and Regulation.

  2017cites this paper
• Eukaryotic translation initiation factor 4E (eIF-4E) expressions are associated with poor prognosis in colorectal adenocarcinoma.

  2017cites this paper
• Identification of perturbed signaling pathways from gene expression data using information divergence.

  2017cites this paper
• Implication of 4E-BP1 protein dephosphorylation and accumulation in pancreatic cancer cell death induced by combined gemcitabine and TRAIL

  2017cites this paper
• Mango polyphenolics reduce inflammation in intestinal colitis—involvement of the miR‐126/PI3K/AKT/mTOR axis in vitro and in vivo

  2017influential citation
• Expression of mTOR/70S6K signaling pathway in pathological scar fibroblasts and the effects of resveratrol intervention

  2017cites this paper
• Pomegranate polyphenolics reduce inflammation and ulceration in intestinal colitis-involvement of the miR-145/p70S6K1/HIF1α axis in vivo and in vitro.

  2017cites this paper
• Translationally controlled tumour protein TCTP is induced early in human colorectal tumours and contributes to the resistance of HCT116 colon cancer cells to 5-FU and oxaliplatin

  2017cites this paper
• Dose–response effects of aerobic exercise on body composition among colon cancer survivors: a randomised controlled trial

  2017cites this paper
• Investigating the effects of aspirin on cell invasion, epithelial-mesenchymal transition and cancer stem cell population in colorectal cancer

  2017cites this paper
• SiRNA Targeting mTOR Effectively Prevents the Proliferation and Migration of Human Lens Epithelial Cells

  2016cites this paper
• Comparison of anti-inflammatory mechanisms of mango (Mangifera Indica L.) and pomegranate (Punica Granatum L.) in a preclinical model of colitis.

  2016cites this paper
• Plum polyphenols inhibit colorectal aberrant crypt foci formation in rats: potential role of the miR-143/protein kinase B/mammalian target of rapamycin axis.

  2016cites this paper
• Improvement of the BALB/c-3T3 cell transformation assay: a tool for investigating cancer mechanisms and therapies

  2016cites this paper
• Autophagy inhibition sensitizes WYE-354-induced anti-colon cancer activity in vitro and in vivo

  2016cites this paper
• Integrin β6 acts as an unfavorable prognostic indicator and promotes cellular malignant behaviors via ERK-ETS1 pathway in pancreatic ductal adenocarcinoma (PDAC)

  2016cites this paper
• Discovery of (S)-4-isobutyloxazolidin-2-one as a novel leucyl-tRNA synthetase (LRS)-targeted mTORC1 inhibitor.

  2016cites this paper
• Palmitoylethanolamide Exerts Antiproliferative Effect and Downregulates VEGF Signaling in Caco‐2 Human Colon Carcinoma Cell Line Through a Selective PPAR‐α‐Dependent Inhibition of Akt/mTOR Pathway

  2016influential citation
• Eukaryotic initiation factor 4E-binding protein 1 (4E-BP1): a master regulator of mRNA translation involved in tumorigenesis

  2016cites this paper
• Gankyrin activates mTORC1 signaling by accelerating TSC2 degradation in colorectal cancer.

  2016cites this paper
• The Courage Trial: A Phase II Randomized Clinical Trial to Evaluate the Dose-Response Effects of Exercise on Prognostic Biomarkers Among Colon Cancer Survivors

  2016cites this paper
• mTOR inhibitors induce apoptosis in colon cancer cells via CHOP-dependent DR5 induction upon 4E-BP1 dephosphorylation

  2015cites this paper
• Original Article Expression of phosphorylated mTOR and its clinical significances in small cell lung cancer

  2015cites this paper
• Halofuginone inhibits colorectal cancer growth through suppression of Akt/mTORC1 signaling and glucose metabolism

  2015cites this paper
• The mTOR pathway in obesity driven gastrointestinal cancers: Potential targets and clinical trials

  2015cites this paper
• The preclinical evaluation of the dual mTORC1/2 inhibitor INK-128 as a potential anti-colorectal cancer agent

  2015cites this paper
• Expression of phosphorylated mTOR and its clinical significances in small cell lung cancer.

  2015cites this paper
• Targeting sphingosine kinase 2 (SphK2) by ABC294640 inhibits colorectal cancer cell growth in vitro and in vivo

  2015cites this paper
• DNA-PKcs interference sensitizes colorectal cancer cells to a mTOR kinase inhibitor WAY-600.

  2015cites this paper
• PC-1/PrLZ confers resistance to rapamycin in prostate cancer cells through increased 4E-BP1 stability

  2015cites this paper
• Mitochondrial DNA copy number in colorectal cancer: between tissue comparisons, clinicopathological characteristics and survival.

  2015cites this paper
• mTOR Inhibition Induces EGFR Feedback Activation in Association with Its Resistance to Human Pancreatic Cancer

  2015cites this paper
• AZD-4547 exerts potent cytostatic and cytotoxic activities against fibroblast growth factor receptor (FGFR)-expressing colorectal cancer cells

  2015cites this paper
• miRNA-99b-5p suppresses liver metastasis of colorectal cancer by down-regulating mTOR

  2015cites this paper
• Dual phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor is an effective radiosensitizer for colorectal cancer.

  2015cites this paper
• The synergistic effect of rapamycin combined with 5-fluorouracil in BALB/cByJNarl mice bearing CT-26 tumor cells.

  2014cites this paper
• The zinc sensing receptor, ZnR/GPR39, controls proliferation and differentiation of colonocytes and thereby tight junction formation in the colon

  2014cites this paper
• mTOR expression in colorectal adenoma.

  2014cites this paper
• Les facteurs de transcription MAF dans l’oncogenèse : implication de NRL dans le médulloblastome

  2014cites this paper
• TOPIC HIGHLIGHT

  2014cites this paper
• Regulation of the cell cycle and PI3K/Akt/mTOR signaling pathway by tanshinone I in human breast cancer cell lines

  2014cites this paper
• PGE2-induced colon cancer growth is mediated by mTORC1.

  2014cites this paper
• A combination of eicosapentaenoic acid-free fatty acid, epigallocatechin-3-gallate and proanthocyanidins has a strong effect on mTOR signaling in colorectal cancer cells.

  2014cites this paper
• Targeting the JNK signaling pathway potentiates the antiproliferative efficacy of Rapamycin in LS17 4T colon cancer cells

  2014cites this paper
• Selective targeting of human colon cancer stem-like cells by the mTOR inhibitor Torin-1

  2013cites this paper
• Phase II trial of temsirolimus alone and in combination with irinotecan for KRAS mutant metastatic colorectal cancer: Outcome and results of KRAS mutational analysis in plasma

  2013cites this paper
• Dysregulation and crosstalk of cellular signaling pathways in colon carcinogenesis.

  2013cites this paper
• Combination of mTOR and EGFR Kinase Inhibitors Blocks mTORC1 and mTORC2 Kinase Activity and Suppresses the Progression of Colorectal Carcinoma

  2013cites this paper
• Polyphenolics from Mango (Mangifera indica L.) and Pomegranate (Punica granatum L.) Suppress Inflammation in in vivo and in vitro Models for Colitis

  2013influential citation
• mTOR pathway in colorectal cancer: an update

  2013cites this paper